A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Haleon PLC stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 523 shares of HLN stock, worth $4,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares
523
Previous 623 16.05%
Holding current value
$4,879
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$8.32 - $10.7 $832 - $1,070
-100 Reduced 16.05%
523 $5,000
Q2 2024

Aug 15, 2024

BUY
$8.01 - $8.64 $801 - $864
100 Added 19.12%
623 $5,000
Q3 2023

Nov 09, 2023

SELL
$7.85 - $8.94 $1,570 - $1,788
-200 Reduced 27.66%
523 $4,000
Q4 2022

Mar 02, 2023

BUY
$5.96 - $8.06 $2,419 - $3,272
406 Added 128.08%
723 $5,000
Q3 2022

Nov 15, 2022

BUY
$5.63 - $7.5 $1,784 - $2,377
317 New
317 $2,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.